EVALUATING THE POTENTIAL OF ADIPOSE TISSUE-DERIVED MSCS AS ANTICANCER GENE DELIVERY VEHICLES TO BONE-METASTASIZED PROSTATE CANCER

The Administrators Of Tulane Educational Fund

Investigators